In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.
Ten isolates of the recently delineated genospecies Borrelia spielmanii were tested against antimicrobial agents used to treat Lyme disease and compared to eight isolates of the other three human-pathogenic borrelial genospecies. Despite some small but significant differences in four out of eight antibiotic agents, the susceptibility pattern of B. spielmanii mainly parallels that of the other known human-pathogenic members of the B. burgdorferi sensu lato complex.
Morgenstern
Kristina
K
Institute of Medical Microbiology and Infection Control, University Hospital of Frankfurt, Frankfurt, Main, Germany. Kristina.Morgenstern@vetmed.uni-giessen.de
Baljer
Georg
G
Norris
Douglas E
DE
Kraiczy
Peter
P
Hanssen-Hübner
Christa
C
Hunfeld
Klaus-Peter
KP
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D025065:Borrelia burgdorferi / Q000235:genetics*; D015748:Borrelia burgdorferi Group / Q000145:classification* / Q000235:genetics* / Q000302:isolation & purification; D017408:Guidelines as Topic; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy* / Q000235:genetics; D008826:Microbial Sensitivity Tests; D013997:Time Factors
D000890:Anti-Infective Agents